High-throughput screening for identification of influenza a inhibitors using a cell-based immunofluorescence assay
Open Access
- 6 June 2025
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 240, 106209
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (U19 AI142759)
This publication has 27 references indexed in Scilit:
- High-Throughput cell-based immunofluorescence assays against influenzaSLAS Discovery, 2023
- Development of an HiBiT‐tagged reporter H3N2 influenza A virus and its utility as an antiviral screening platformJournal of Medical Virology, 2022
- Generation, Characterization, and Applications of Influenza A Reporter Viruses2022
- Benchmarking the mechanisms of frequent hitters: limitation of PAINS alertsDrug Discovery Today, 2021
- Baloxavir marboxil susceptibility of influenza viruses from the Asia-Pacific, 2012–2018Antiviral Research, 2019
- In vitro characterization of baloxavir acid, a first-in-class cap-dependent endonuclease inhibitor of the influenza virus polymerase PA subunitAntiviral Research, 2018
- Identification of Small Molecules that Interfere with H1N1 Influenza A Viral ReplicationChemMedChem, 2012
- Identification of novel virus inhibitors by influenza A virus specific reporter cell based screeningAntiviral Research, 2012
- A cell-based luminescence assay is effective for high-throughput screening of potential influenza antiviralsAntiviral Research, 2007
- In vitro and in vivo influenza virus-inhibitory effects of viramidineAntiviral Research, 2005